These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6163816)

  • 21. Sensitization of lymphocytes against pooled allogeneic cells. II. Characterization of effector cells cytotoxic for autologous lymphoblastoid cell lines.
    Zarling JM; Bach FH; Kung PC
    J Immunol; 1981 Jan; 126(1):375-8. PubMed ID: 6450239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of monoclonal antibodies directed against murine T lymphocyte cell surface antigens on lymphokine production by cloned T lymphocytes reactive with class I MHC or Mls alloantigens.
    Lancki DW; Prystowsky MB; Vogel SN; Beller DI; Dialynas DP; Fitch FW
    J Immunol; 1984 Oct; 133(4):2051-7. PubMed ID: 6236262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells.
    Kobayashi H; Nagato T; Takahara M; Sato K; Kimura S; Aoki N; Azumi M; Tateno M; Harabuchi Y; Celis E
    Cancer Res; 2008 Feb; 68(3):901-8. PubMed ID: 18245493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lysis of P3HR-1 cells induced to enter the viral cycle by antibody-dependent and independent immunological mechanisms.
    Kurakata S; Ramos OF; Klein G; Klein E
    Cell Immunol; 1989 Oct; 123(1):134-47. PubMed ID: 2550147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune responses to Herpesvirus sylvilagus infection in cottontail rabbits.
    Yang WC; Hesselton RM; Sullivan JL
    J Immunol; 1990 Sep; 145(6):1929-33. PubMed ID: 2167913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA antigen-related restriction of T lymphocyte cytotoxicity to Epstein-Barr virus.
    Misko IS; Moss DJ; Pope JH
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4247-50. PubMed ID: 6254017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and release of plasminogen activator by lymphoid cell lines of malignant origin and its effect on lymphocyte cytotoxicity.
    Sundar SK; Bergeron J; Menezes J
    Exp Biol; 1985; 43(4):277-85. PubMed ID: 2989001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recognition of transformed cells by autologous lymphocytes: a review.
    Klein E; Kedar E; Wang P; Vánky F
    In Vivo; 1991; 5(6):625-9. PubMed ID: 1667269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allo-restricted cytotoxicity recognizing EBV-determined antigens. Comments.
    Klein E; Torsteinsdottir S; Masucci MG
    J Mol Cell Immunol; 1987; 3(3):195-7. PubMed ID: 2855407
    [No Abstract]   [Full Text] [Related]  

  • 30. Stimulation of normal lymphocytes with autologous lymphoid cell lines: properties of derived killer cells.
    Svedmyr E; Jondal M; Leibold W
    Scand J Immunol; 1975; 4(7):721-34. PubMed ID: 173017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal antibodies against RT1a antigens.
    Elsässer-Beile U; Günther E
    Transplant Proc; 1979 Sep; 11(3):1571-3. PubMed ID: 315629
    [No Abstract]   [Full Text] [Related]  

  • 32. Lysis of autologous Epstein-Barr virus-infected B cells by cytotoxic T lymphocytes of rheumatoid arthritis patients.
    Tsoukas CD; Carson DA; Fong S; Slovin SF; Fox RI; Vaughan JH
    Clin Immunol Immunopathol; 1982 Jul; 24(1):8-14. PubMed ID: 6179673
    [No Abstract]   [Full Text] [Related]  

  • 33. Morphologic observations of contact-induced lysis of EBV-infected B lymphocytes by autologous hand mirror T cells.
    Thomas WJ; Duval-Arnould B; Creegan WJ; Schumacher HR; Forman DS; Strong DM
    Am J Hematol; 1982 Apr; 12(2):109-19. PubMed ID: 6280495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation of Ia-like antigen-bearing cells from human peripheral lymphocytes through the use of a monoclonal antibody to framework determinants of Ia-like antigens.
    Indiveri F; Ng AK; Russo C; Quaranta V; Pellegrino MA; Ferrone S
    J Immunol Methods; 1980; 39(4):343-54. PubMed ID: 6161968
    [No Abstract]   [Full Text] [Related]  

  • 35. IgM monoclonal antibody JD118 recognizes an inducible antigen target for human-complement-mediated cytotoxicity against neoplastic B cells.
    Czuczman MS; Garin-Chesa P; Lemoli RM; Scheinberg DA
    Cancer Immunol Immunother; 1993 Jun; 36(6):387-96. PubMed ID: 8500111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different sensitivity of B cell lines derived from Burkitt lymphoma (BL) and normal cells (LCL) to cytotoxic T cell clones generated by autologous and allogeneic stimulation.
    Klein E; Torsteinsdottir S; Masucci MG; Klein G
    J Immunogenet; 1986; 13(2-3):269-74. PubMed ID: 3029233
    [No Abstract]   [Full Text] [Related]  

  • 37. Correlated expression of a B-lymphocyte-specific glycoprotein (gp27/35) and the EBV receptor/C3 receptor complex in sublines from the same Burkitt lymphoma.
    Klein G; Hyman R; Trowbridge I
    Int J Cancer; 1979 Jan; 23(1):37-41. PubMed ID: 215562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness.
    Zinkernagel RM; Doherty PC
    Adv Immunol; 1979; 27():51-177. PubMed ID: 92183
    [No Abstract]   [Full Text] [Related]  

  • 39. Adhesion molecules, immunosurveillance, and B-cell malignancies.
    Lancet; 1988 Jan; 1(8579):248-9. PubMed ID: 2893077
    [No Abstract]   [Full Text] [Related]  

  • 40. Stimulation of peripheral human lymphocytes by autologous EBV genome-carrying lymphoblastoid cell lines.
    Viallat J; Svedmyr E; Steinitz M; Klein G
    Cell Immunol; 1978 Jun; 38(1):68-75. PubMed ID: 208783
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.